A randomized controlled trial on the effectiveness of Fengreqing oral liquid in the treatment of upper respiratory tract infection based on the actual medical environment

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2023
INTERVENTION: Experimental group:Fengreqing oral liquid;Control group:Yinhuang oral liquid; CONDITION: upper respiratory tract infection PRIMARY OUTCOME: Recovery rate;Pharyngeal pain disappearance rate; INCLUSION CRITERIA: 1. Comply with the diagnostic criteria of western medicine for acute upper respiratory tract infection; 2. Conform to the syndrome differentiation standard of exogenous wind‐heat syndrome in traditional Chinese medicine; 3. Aged 18‐75 years; 4. Pharyngeal pain VAS >= 4 points; 5. Agree and sign the informed consent form.
Epistemonikos ID: 4a328dcfe58f22affac97ee32179f977f9e12222
First added on: Feb 20, 2024